Literature DB >> 11493448

Stromal cells expressing ephrin-B2 promote the growth and sprouting of ephrin-B2(+) endothelial cells.

X Q Zhang1, N Takakura, Y Oike, T Inada, N W Gale, G D Yancopoulos, T Suda.   

Abstract

Ephrin-B2 is a transmembrane ligand that is specifically expressed on arterial endothelial cells (ECs) and surrounding cells and interacts with multiple EphB class receptors. Conversely, EphB4, a specific receptor for ephrin-B2, is expressed on venous ECs, and both ephrin-B2 and EphB4 play essential roles in vascular development. The bidirectional signals between EphB4 and ephrin-B2 are thought to be specific for the interaction between arteries and veins and to regulate cell mixing and the making of particular boundaries. However, the molecular mechanism during vasculogenesis and angiogenesis remains unclear. Manipulative functional studies were performed on these proteins in an endothelial cell system. Using in vitro stromal cells (OP9 cells) and a paraaortic splanchnopleura (P-Sp) coculture system, these studies found that the stromal cells expressing ephrin-B2 promoted vascular network formation and ephrin-B2(+) EC proliferation and that they also induced the recruitment and proliferation of alpha-smooth muscle actin (alpha-SMA)-positive cells. Stromal cells expressing EphB4 inhibited vascular network formation, ephrin-B2(+) EC proliferation, and alpha-SMA(+) cell recruitment and proliferation. Thus, these data suggest that ephrin-B2 and EphB4 mediate reciprocal interactions between arterial and venous ECs and surrounding cells to form each characteristic vessel. (Blood. 2001;98:1028-1037)

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11493448     DOI: 10.1182/blood.v98.4.1028

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  13 in total

1.  Identification and characterization of a resident vascular stem/progenitor cell population in preexisting blood vessels.

Authors:  Hisamichi Naito; Hiroyasu Kidoya; Susumu Sakimoto; Taku Wakabayashi; Nobuyuki Takakura
Journal:  EMBO J       Date:  2011-12-16       Impact factor: 11.598

2.  EphB4 controls blood vascular morphogenesis during postnatal angiogenesis.

Authors:  Ralf Erber; Uta Eichelsbacher; Violetta Powajbo; Tobias Korn; Valentin Djonov; Jihong Lin; Hans-Peter Hammes; Rainer Grobholz; Axel Ullrich; Peter Vajkoczy
Journal:  EMBO J       Date:  2006-01-19       Impact factor: 11.598

3.  Emerging pulmonary vasculature lacks fate specification.

Authors:  Margaret A Schwarz; Lauren Caldwell; Danielle Cafasso; Haihua Zheng
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-10-24       Impact factor: 5.464

Review 4.  Biomedicine and diseases: the Klippel-Trenaunay syndrome, vascular anomalies and vascular morphogenesis.

Authors:  A A Timur; D J Driscoll; Q Wang
Journal:  Cell Mol Life Sci       Date:  2005-07       Impact factor: 9.261

5.  Angiogenesis QTL on Mouse Chromosome 8 Colocalizes with Differential β-Defensin Expression.

Authors:  Jason Smith; Fang Liu; Barbara Beyer; Krista Morales; Andrew Reilly; Richard Cole; Bruce J Herron
Journal:  J Biomol Tech       Date:  2015-07

6.  The ephrinB2/EphB4 axis is dysregulated in osteoprogenitors from myeloma patients and its activation affects myeloma bone disease and tumor growth.

Authors:  Angela Pennisi; Wen Ling; Xin Li; Sharmin Khan; John D Shaughnessy; Bart Barlogie; Shmuel Yaccoby
Journal:  Blood       Date:  2009-07-13       Impact factor: 22.113

7.  Reprogrammed mouse fibroblasts differentiate into cells of the cardiovascular and hematopoietic lineages.

Authors:  Katja Schenke-Layland; Katrin E Rhodes; Ekaterini Angelis; Yekaterina Butylkova; Sepideh Heydarkhan-Hagvall; Christos Gekas; Rui Zhang; Joshua I Goldhaber; Hanna K Mikkola; Kathrin Plath; W Robb MacLellan
Journal:  Stem Cells       Date:  2008-05-01       Impact factor: 6.277

Review 8.  Human placental microRNAs and preeclampsia.

Authors:  Dong-bao Chen; Wen Wang
Journal:  Biol Reprod       Date:  2013-05-23       Impact factor: 4.285

9.  Inhibition of choroidal neovascularization by anti-EphB4 monoclonal antibody.

Authors:  Dongfeng Su; Xiaoqiu Li; Dianwen Gao
Journal:  Exp Ther Med       Date:  2013-02-18       Impact factor: 2.447

10.  Effects of overexpression of ephrin-B2 on tumour growth in human colorectal cancer.

Authors:  W Liu; Y D Jung; S A Ahmad; M F McCarty; O Stoeltzing; N Reinmuth; F Fan; L M Ellis
Journal:  Br J Cancer       Date:  2004-04-19       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.